Blood Relatives: Dynamic Regulation of Bioactive Lysophosphatidic Acid and Sphingosine-1-Phosphate Metabolism in the Circulation

Trends in Cardiovascular Medicine

Volumn 19, Issue 4, 2009, Pages 135-140

  Morris, Andrew J ^a,b   Selim, Samy ^a,b   Salous, Abdel ^a,b   Smyth, Susan S ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b LEXINGTON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AUTOTAXIN; LIPID PHOSPHATE PHOSPHATASE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPASE; PHOSPHATASE; SERUM ALBUMIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2; UNCLASSIFIED DRUG;

CELLULAR DISTRIBUTION; DEPHOSPHORYLATION; EMBRYONIC STEM CELL; ERYTHROCYTE; LIPID BLOOD LEVEL; LIPID METABOLISM; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE; VASCULAR ENDOTHELIUM;

ANIMALS; CARDIOVASCULAR SYSTEM; HUMANS; LYSOPHOSPHOLIPIDS; MICE; MODELS, ANIMAL; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOSINE; TIME FACTORS;

EID: 70349776386     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2009.07.005     Document Type: Review

References (37)

1. Aoki J., Taira A., Takanezawa Y., et al. Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 277 (2002) 48737-48744
2. Baker D.L., Desiderio D.M., Miller D.D., et al. Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry. Anal Biochem 292 (2001) 287-295
3. Baker D.L., Morrison P., Miller B., et al. Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA 287 (2002) 3081-3082
4. Brindley D.N., and Pilquil C. Lipid phosphate phosphatases and signaling. J Lipid Res 50 Suppl (2009) S225-S230
5. Escalante-Alcalde D., Hernandez L., Le Stunff H., et al. The lipid phosphatase LPP3 regulates extra-embryonic vasculogenesis and axis patterning. Development 130 (2003) 4623-4637
6. Federico L., Pamuklar Z., Smyth S.S., and Morris A.J. Therapeutic potential of autotaxin/lysophospholipase d inhibitors. Curr Drug Targets 9 (2008) 698-708
7. Hanel P., Andreani P., and Graler M.H. Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J 21 (2007) 1202-1209
8. Hla T., and Im D.S. Cell biology. The ABCs of lipophile transport. Science 323 (2009) 883-884
9. Kanda H., Newton R., Klein R., et al. Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat Immunol 9 (2008) 415-423
10. Kawahara A., Nishi T., Hisano Y., et al. The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. Science 323 (2009) 524-527
11. Kimura T., Sato K., Kuwabara A., et al. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. J Biol Chem 276 (2001) 31780-31785
12. Law C.J., Maloney P.C., and Wang D.N. Ins and outs of major facilitator superfamily antiporters. Annu Rev Microbiol 62 (2008) 289-305
13. Maceyka M., Sankala H., Hait N.C., et al. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J Biol Chem 280 (2005) 37118-37129
14. McIntyre T.M., Pontsler A.V., Silva A.R., et al. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc Natl Acad Sci U S A 100 (2003) 131-136
15. Mitra P., Oskeritzian C.A., Payne S.G., et al. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci U S A 103 (2006) 16394-16399
16. Noguchi K., Herr D., Mutoh T., and Chun J. Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol 9 (2009) 15-23
17. Ohkawa R., Nakamura K., Okubo S., et al. Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters. Ann Clin Biochem 45 (2008) 356-363
18. Osborne N., Brand-Arzamendi K., Ober E.A., et al. The spinster homolog, two of hearts, is required for sphingosine 1-phosphate signaling in zebrafish. Curr Biol 18 (2008) 1882-1888
19. Pamuklar Z., Federico L., Liu S., et al. Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis. J Biol Chem 284 (2009) 7385-7394
20. Pappu R., Schwab S.R., Cornelissen I., et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 316 (2007) 295-298
21. Renault A.D., Sigal Y.J., Morris A.J., and Lehmann R. Soma-germ line competition for lipid phosphate uptake regulates germ cell migration and survival. Science 305 (2004) 1963-1966
22. Rosen H., Gonzalez-Cabrera P., Marsolais D., et al. Modulating tone: the overture of S1P receptor immunotherapeutics. Immunol Rev 223 (2008) 221-235
23. Rosen H., Gonzalez-Cabrera P.J., Sanna M.G., and Brown S. Sphingosine 1-phosphate receptor signaling. Annu Rev Biochem (2009)
24. Sehnert A.J., and Stainier D.Y. A window to the heart: can zebrafish mutants help us understand heart disease in humans?. Trends Genet 18 (2002) 491-494
25. Sigal Y.J., McDermott M.I., and Morris A.J. Integral membrane lipid phosphatases/phosphotransferases: common structure and diverse functions. Biochem J 387 (2005) 281-293
26. Smyth S.S., Cheng H.Y., Miriyala S., et al. Roles of lysophosphatidic acid in cardiovascular physiology and disease. Biochim Biophys Acta 1781 (2008) 563-570
27. Tanaka M., Okudaira S., Kishi Y., et al. Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J Biol Chem 281 (2006) 25822-25830
28. Tanyi J.L., Morris A.J., Wolf J.K., et al. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer. Cancer Res 63 (2003) 1073-1082
29. Theilmeier G., Schmidt C., Herrmann J., et al. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 114 (2006) 1403-1409
30. Tokumura A., Majima E., Kariya Y., et al. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 277 (2002) 39436-39442
31. Tomsig J.L., Snyder A.H., Berdyshev E.V., et al. Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo. Biochem J 419 (2009) 611-618
32. Van Meeteren L.A., and Moolenaar W.H. Regulation and biological activities of the autotaxin-LPA axis. Prog Lipid Res 46 (2007) 145-160
33. Van Meeteren L.A., Ruurs P., Christodoulou E., et al. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate. J Biol Chem 280 (2005) 21155-21161
34. Van Meeteren L.A., Ruurs P., Stortelers C., et al. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol Cell Biol 26 (2006) 5015-5022
35. Venkataraman K., Lee Y.M., Michaud J., et al. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 102 (2008) 669-676
36. Xu Y., Shen Z., Wiper D.W., et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 280 (1998) 719-723
37. Yatomi Y., Igarashi Y., Yang L., et al. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem 121 (1997) 969-973